214 related articles for article (PubMed ID: 30398157)
1. Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma.
Papoudou-Bai A; Marinos L; Papathanasiou K; Kanavaros P; Kapsali E
Turk J Haematol; 2018 Nov; 35(4):308-309. PubMed ID: 30398157
[No Abstract] [Full Text] [Related]
2. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
[TBL] [Abstract][Full Text] [Related]
3. Unusual sequence of lymphoid disorders: follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma.
Niscola P; Palombi M; Fratoni S; Trawinska MM; Scaramucci L; Giovannini M; Perrotti A; De Fabritiis P
Acta Oncol; 2009; 48(7):1073-4. PubMed ID: 19308758
[No Abstract] [Full Text] [Related]
4. Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma.
Hwang YY; Leung AY; Lau WH; Loong F; So JC; Tse E; Kwong YL
Histopathology; 2011 Aug; 59(2):352-5. PubMed ID: 21884219
[No Abstract] [Full Text] [Related]
5. Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.
Dargent JL; Lespagnard L; Meiers I; Bradstreet C; Heimann P; De Wolf-Peeters C
Virchows Arch; 2005 Oct; 447(4):778-80. PubMed ID: 15983819
[No Abstract] [Full Text] [Related]
6. [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
Uchida T; Sugimoto K; Koike M
Rinsho Ketsueki; 2009 Feb; 50(2):83-6. PubMed ID: 19265299
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
8. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
Chan TS; Khong PL; Kwong YL
Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
[No Abstract] [Full Text] [Related]
10. CD 30-positive transformed follicular lymphoma: two case reports and literature review.
Montes-Moreno S; Climent F; González de Villambrosía S; González Barca EM; Batlle A; Insunza A; Pané-Foix M; Colorado M; Martin-Sánchez G; Espiga CR; Conde E; Piris MA
Histopathology; 2015 Dec; 67(6):918-22. PubMed ID: 25953530
[TBL] [Abstract][Full Text] [Related]
11. Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.
Menon MP; Hutchinson L; Garver J; Jaffe ES; Woda BA
J Clin Oncol; 2013 Feb; 31(5):e53-6. PubMed ID: 23295788
[No Abstract] [Full Text] [Related]
12. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
[TBL] [Abstract][Full Text] [Related]
13. [Malignant lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)].
Kinoshita T
Rinsho Ketsueki; 2012 Feb; 53(2):145-54. PubMed ID: 22450573
[No Abstract] [Full Text] [Related]
14. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
[TBL] [Abstract][Full Text] [Related]
16. [Ambulatory endoxan therapy by high doses].
Fischer M; Martin H; Schubert JC
Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
[No Abstract] [Full Text] [Related]
17. Present management of the lymphomas.
Kabakow B
Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():39-45. PubMed ID: 4950557
[No Abstract] [Full Text] [Related]
18. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Dakhil S; Hermann R; Schreeder MT; Gregory SA; Monte M; Windsor KS; Hurst D; Chai A; Brewster M; Richards P
Leuk Lymphoma; 2014 Oct; 55(10):2335-40. PubMed ID: 24471908
[TBL] [Abstract][Full Text] [Related]
19. A tale of two cancers: collision presentation of ovarian carcinoma and lymphoma.
Singhal N; Quilty S; George M; Davy M; Selva Nayagam S
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):232-4. PubMed ID: 19432618
[TBL] [Abstract][Full Text] [Related]
20. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
